Form 4: Merck Director Acquires Phantom Stock Units

Merck & Co. Director Mary Ellen Coe reported the acquisition of 285.0086 phantom stock units, to be settled in cash upon termination of service, and holds 29,231.5716 derivative securities.

Summary

• Mary Ellen Coe, a Director at Merck & Co., Inc., filed a Form 4 reporting changes in her beneficial ownership.
• The filing indicates the acquisition of 285.0086 phantom stock units on December 31, 2025.
• These phantom stock units are convertible on a 1-for-1 basis to common stock but will be settled 100% in cash upon Ms. Coe's termination of service, as per a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.
• The price of the derivative security (phantom stock) at the time of acquisition was $105.26 per unit.
• Following this transaction, Ms. Coe beneficially owns a total of 29,231.5716 derivative securities, which includes units acquired through dividend reinvestment transactions.
• She also directly owns 10 shares of Merck & Co., Inc. common stock.

Sentiment

Score: 5

Explanation: The filing is a routine Form 4 reporting an insider transaction, which typically has a neutral sentiment unless the transaction is unusually large or indicative of a significant shift in insider confidence. The acquisition of phantom stock units is part of a compensation plan.

Positives

• Director Mary Ellen Coe increased her beneficial ownership of derivative securities, which can be seen as aligning her interests with those of shareholders.
• The acquisition of phantom stock units demonstrates continued participation in the company's long-term compensation plans for directors.

Negatives

• NA

Risks

• NA

Future Outlook

Phantom stock units are scheduled to be settled 100% in cash upon the reporting person's termination of service, in accordance with an elected distribution schedule under the Plan for Deferred Payment of Directors' Compensation.

Management Comments

• NA

Industry Context

This is a standard insider transaction filing, common for directors and officers of publicly traded companies, reflecting changes in their beneficial ownership of company securities as part of compensation plans. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• The acquisition of phantom stock units by a director is a transaction between a related party (director) and the company, conducted under a pre-existing, disclosed compensation plan.

Stakeholder Impact

• Shareholders: Minor positive impact due to increased director alignment with company performance through equity-linked compensation.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Next Steps

• Settlement of phantom stock units in cash upon the reporting person's termination of service, as per the deferred compensation plan.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of phantom stock units by a director as part of a compensation plan. It does not provide new information that would significantly alter the investment thesis for Merck & Co., Inc., thus a 'hold' recommendation is appropriate.

Keywords

Merck, MRK, Form 4, insider transaction, phantom stock, director compensation, beneficial ownership, equity compensation